PLEDPHARMA PRESENTS TOP-LINE RESULTS FROM ITS PHASE IIb STUDY – PLEDOX® REDUCES NERVE DAMAGE IN CONJUNCTION WITH CHEMOTHERAPY BY 43 PERCENT PledPharma AB (publ) today announces top-line results from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results